PEPTIQORE™
PQ-IM-TIR-004·Sequence-Related ImpurityMade to Order

Tirzepatide Truncation-Related Impurity Reference Material

Truncation impurities arise from premature chain termination and are relevant to Tirzepatide purity profiling.

PARENT PEPTIDE

Tirzepatide

MATERIAL TYPE

Sequence-Related Impurity

TARGET PURITY

≥90% (HPLC)

EVIDENCE STATUS

Peer-Reviewed

Made to Order

QUANTITY

1 mg5 mgCustom
Request Material Quote

DOCUMENTATION

HPLC purity
LC-MS mass confirmation
Certificate of Analysis

QUALITY CONTEXT

Why This Record Matters

Truncated Tirzepatide materials are present in competitor catalogs, confirming market demand. Specific truncation position to be selected based on synthesis feasibility.

POTENTIAL ORIGIN

Premature termination or deletion during solid-phase synthesis of the 39-residue Tirzepatide sequence.

Analytical Data Package

HPLC Purity Data
LC-MS Mass Confirmation
MS/MS Fragmentation
Certificate of Analysis

PEPTIQORE APPROACH

Quality Record
Supporting Evidence
Analytical Data
Related Impurities
Analytical Method Context
Experimental Support

TRADITIONAL SUPPLIER

Product → CoA

IMPURITY CLASSIFICATION

Sequence-Related Impurity

EVIDENCE STATUS

Peer-Reviewed

PARENT PEPTIDE

Tirzepatide Quality Hub →

CUSTOM DEVELOPMENT

Can't Find Your Impurity?

PeptiQore supports custom development of peptide-related impurities, sequence variants and degradation materials.

Request Custom Impurity Development